Lu, Rui
Xiang, Haifei
Zhu, Minshu
Cao, Yan
Shao, Xiandong
Yu, Guo
Tung, Tao-Hsin
Du, Wenjie
Chen, Lingyang
Cao, Jianbin
Wang, Mingcang
Article History
Received: 17 October 2024
Accepted: 17 December 2024
First Online: 19 February 2025
Declarations
:
: This study was approved by the Medical Ethics Committee of Taizhou Enze Medical Centre (Group) Enze Hospital, Taizhou, Zhejiang, China (approval no. K20220307) on 28 March 2022. All participants provided written informed consent before participation. The trial followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines and was registered before patient recruitment at the Chinese Clinical Trial Registry (registration no. ChiCTR2200065407; date of registration: November 4, 2022).
: Not applicable.
: The authors declare no competing interests.